BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 34319047)

  • 21. The Stem Cell-associated Transcription Factor SOX2 as a Diagnostic Marker of High-grade Squamous Intraepithelial Lesion of the Uterine Cervix in Comparison With p16 and Ki-67.
    Wolsky RJ; Harbour LN; Mirza KM; Montag AG; Gwin K
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):403-410. PubMed ID: 27490766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [p16INK4A overexpression is a useful marker for uterine cervix lesions].
    Missaoui N; Hmissa S; Sankaranarayanan R; Deodhar K; Nene B; Budukh A; Malvi S; Chinoy R; Kelkar R; Kane S; Chauhan M; Kothai A; Kahate S; Fontanière B; Frappart L
    Ann Biol Clin (Paris); 2010; 68(4):409-14. PubMed ID: 20650735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.
    Negri G; Vittadello F; Romano F; Kasal A; Rivasi F; Girlando S; Mian C; Egarter-Vigl E
    Virchows Arch; 2004 Dec; 445(6):616-20. PubMed ID: 15480761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.
    Kisser A; Zechmeister-Koss I
    BJOG; 2015 Jan; 122(1):64-70. PubMed ID: 25208923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
    Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
    Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
    Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
    Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model.
    Kruse AJ; Baak JP; Janssen EA; Kjellevold KH; Fiane B; Lovslett K; Bergh J; Robboy S
    Cell Oncol; 2004; 26(1-2):13-20. PubMed ID: 15371653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular Correlations.
    Fusco N; Guerini-Rocco E; Del Gobbo A; Franco R; Zito-Marino F; Vaira V; Bulfamante G; Ercoli G; Nosotti M; Palleschi A; Bosari S; Ferrero S
    PLoS One; 2015; 10(12):e0144923. PubMed ID: 26674347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16INK4a and Ki-67 measurement predict progression of cervical low-grade squamous intraepithelial lesion.
    Zhang X; Shen D
    Int J Clin Exp Pathol; 2018; 11(8):4109-4116. PubMed ID: 31949802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predict the Progression of Cervical Intraepithelial Neoplasia by a Novel Marker Folate Combine with FRα, p16 and Ki-67.
    Liu T; Chen M; Li X; Wang H
    Int J Gen Med; 2022; 15():6529-6538. PubMed ID: 35971526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycodelin expression in pregnant patients with cervical intraepithelial neoplasia: a case-control study.
    Ciavattini A; Sopracordevole F; Di Giuseppe J; Lucarini G; Zizzi A; Moriconi L; Goteri G
    Gynecol Endocrinol; 2016; 32(4):329-33. PubMed ID: 26631447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between serum P16ink4A concentration and CIN and cervical cancer among women attending a cervical cancer clinic in western Uganda: A case control study.
    Ssedyabane F; Ngonzi J; Tusubira D; Nambi Najjuma J; Kajabwangu R; Okeny C; Nuwashaba D; Namuli A; Niyonzima N
    Gynecol Oncol Rep; 2024 Jun; 53():101388. PubMed ID: 38590932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of p16INK4A in Peripheral White Blood Cells as a Novel Screening Marker for Colorectal Carcinoma.
    Thin KA; Angsuwatcharakon P; Edwards SW; Mutirangura A; Puttipanyalears C
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3753-3761. PubMed ID: 36444588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing Cervical Cancer Screening: Review of p16/Ki-67 Dual Staining as a Promising Triage Strategy.
    Ouh YT; Kim HY; Yi KW; Lee NW; Kim HJ; Min KJ
    Diagnostics (Basel); 2024 Feb; 14(4):. PubMed ID: 38396493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Ki67 index and P16 expression in different grades of cervical squamous intraepithelial lesions.
    Hosseini MS; Talayeh M; Afshar Moghaddam N; Arab M; Farzaneh F; Ashrafganjoei T
    Caspian J Intern Med; 2023; 14(1):69-75. PubMed ID: 36741489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive Value of Marker of Proliferation Ki-67 and Cell Cycle Dependent Protein kinase Inhibitor P16INK4a in Cervical Biopsy to Determine Its Biological Behaviour.
    Sarma U; Das GC; Sarmah B
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2237-2241. PubMed ID: 34319047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of p16INK4a and Ki-67 proteins expression in cervical intraepithelial neoplasia and their correlation with HPV-HR infection].
    Ungureanu C; Teleman S; Socolov D; Anton G; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):823-8. PubMed ID: 21243810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunofluorescence expression of Ki-67, p53 and cyclin inhibitors (p16ink4a, p21 and p27) in low-grade cervical lesions versus high-grade cervical lesions. Research study on cell cultures.
    Stănculescu R; Ceauşu M; Ceauşu Z; Bausic V
    Rom J Morphol Embryol; 2013; 54(3 Suppl):725-34. PubMed ID: 24322019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and grading of cervical intraepithelial neoplasias].
    Rosamilia C; Feichter G; Tzankov A; Obermann EC
    Pathologe; 2012 Mar; 33(2):118-23. PubMed ID: 22350168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16INK4a Expression in Cervical Lesions Correlates with Histologic Grading - a Tertiary Level Medical Facility Based Retrospective Study.
    Sarma U; Biswas I; Das A; Das GC; Saikia C; Sarma B
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2643-2647. PubMed ID: 29072058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.